| |
|
|
|
Five Prime Therapeutics Inc.  
|
|
6.12 -0.29 (-0.05%) |
07-02 16:00 |
|
Open: |
6.56 |
Pre close: |
6.41 |
Target:
|
8.14
|
|
High: |
6.58 |
Low: |
6.08 |
Resistance:
|
6.97
8.14
|
|
Volume: |
241,333 |
Market Cap: |
224M |
Support:
|
5.05
3.87
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.52
 |
MACD |
MACD(12,26):
|
0.54 |
|
MA(20): |
5.07 |
Signal(12,26,9): |
0.32 |
|
MA(100): |
3.91 |
Stochastic Oscillator |
%K(14,3):
|
93.76 |
|
MA(250): |
4.43 |
%D(3): |
89.03 |
|
Average Volume(K) |
3-Month: |
44181
|
52-Week |
High:
|
6.97 |
|
10-Days: |
88508 |
Low: |
1.75 |
|
RSI |
RSI(14):
|
66.87 |
Change(%): |
8.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.470 |
Return on Equity (ttm) |
-66.1 |
Shares Out. (M) |
36.64 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-28.4 |
Shares Float (M) |
24.25 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.06 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
57.4 |
% Held by Institutions |
73.55 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
-2.538 |
Shares Short (K) |
1590 |
|
Book Value (p.s.) |
3.950 |
EBITDA (p.s.) |
-3.078 |
P/E |
-1.97 |
|
Sales Per Share |
0.490 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.73 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-96.26 |
P/S |
13.93 |
|
Operating Margin |
-657.89 |
Levered Free Cash Flow
(M) |
-47.85 |
P/CF |
-2.60 |
|
|
|
|
|
|
